These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 468445)

  • 1. Bioavailability study of gitoxin in a solid dosage form.
    Hupin C; de Suray JM; Versluys J; Lorent M; Dodion L; Lesne M
    Int J Clin Pharmacol Biopharm; 1979 May; 17(5):197-204. PubMed ID: 468445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological reevaluation of gitoxin in man.
    Lesne M
    Int J Clin Pharmacol Biopharm; 1978 Oct; 16(10):456-9. PubMed ID: 700907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the pharmacokinetics and the metabolism of gitoxin in the guinea-pig: I. Disposition kinetics following an i.v. bolus of 3H-gitoxin.
    Kadima LN; Lesne M
    Arch Int Pharmacodyn Ther; 1980 May; 245(1):20-41. PubMed ID: 7406600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enhanced bioavailability of digoxin from silica matrix formulations (author's transl)].
    Flasch H; Asmussen B; Heinz N
    Arzneimittelforschung; 1978; 28(2):326-30. PubMed ID: 205226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological availability of different oral cimetidine preparations in the dog].
    Viernstein H; Plass H; Turnheim K
    Arzneimittelforschung; 1990 Jun; 40(6):675-8. PubMed ID: 2397003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac glycosides and their metabolites levels in plasma and heart of guinea-pigs after I. V. administration.
    Dolphen R; Lesne M
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):4-25. PubMed ID: 7259366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute bioavailability of digoxin tablets.
    Beveridge T; Nüesch E; Ohnhaus EE
    Arzneimittelforschung; 1978; 28(4):701-3. PubMed ID: 581950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac effects of 16-acetyl-gitoxin, the active glycoside after penta-acetyl-gitoxin administration.
    Haustein KO; Hauptmann J; Nowak G
    Acta Biol Med Ger; 1978; 37(11-12):1713-20. PubMed ID: 754425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, bioavailability, and dosage regimens of digoxin in dogs.
    Button C; Gross DR; Johnston JT; Yakatan GJ
    Am J Vet Res; 1980 Aug; 41(8):1230-7. PubMed ID: 7447117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraordinary efficacy of 16 alpha-gitoxin, an ultra-short acting semi-synthetic digitalis glycoside.
    Haustein KO; Bauer R
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):299-304. PubMed ID: 7921531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of digoxin from tablets. II. Radioimmunoassay and disposition pharmacokinetics of digoxin after intravenous administration.
    Nyberg L; Andersson KE; Bertler A
    Acta Pharm Suec; 1974 Nov; 11(5):459-70. PubMed ID: 4440504
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioavailability of digoxin in capsules.
    Padeletti L; Brat A
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):320-2. PubMed ID: 669878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans.
    He ZG; Li YS; Zhang TH; Tang X; Zhao C; Zhang RH
    Pharmazie; 2004 Mar; 59(3):200-2. PubMed ID: 15074593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bioavailability and elimination of various digoxin preparations in the beagle dog and their possible sex dependence (author's transl)].
    Gastauer R; Eltze M; Pabst J
    Arzneimittelforschung; 1979; 29(5):754-7. PubMed ID: 582973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin tablets--a review of the bioavailability problems.
    Sim SK
    Am J Hosp Pharm; 1976 Jan; 33(1):44-8. PubMed ID: 1266866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
    Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting effect on cardiac output of digoxin and gitoxin in humans during congestive heart failure.
    Col J; Wijns W; Brasseur L; Lesne M
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):314-8. PubMed ID: 7263109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penta-acetyl-gitoxin: the prototype of a prodrug in the cardiac glycoside series.
    Megges R; Portius HJ; Repke KR
    Pharmazie; 1977 Nov; 32(11):665-7. PubMed ID: 609583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative bioavailability of three pharmaceutical forms of digoxin].
    Thebault J; Lucas A; d'Athis P; Tillement JP
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):144-7. PubMed ID: 576592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.